These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18991670)

  • 1. Medical management of the diabetic patient with coronary artery disease.
    Karastergiou K; Kaski JC
    Curr Pharm Des; 2008; 14(25):2527-36. PubMed ID: 18991670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trials.
    Bauters C; Lemesle G
    BMC Cardiovasc Disord; 2016 May; 16():90. PubMed ID: 27165687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary revascularization in patients with type 2 diabetes and results of the BARI 2D trial.
    Sobel BE
    Coron Artery Dis; 2010 May; 21(3):189-98. PubMed ID: 20308880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of silent coronary artery disease in type 2 diabetes.
    Zellweger MJ
    Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery.
    Bauer SM; Cayne NS; Veith FJ
    J Vasc Surg; 2010 Jan; 51(1):242-51. PubMed ID: 19954922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and management of coronary artery disease in patients with diabetes mellitus.
    Majid A
    Acta Med Indones; 2009 Jan; 41(1):41-4. PubMed ID: 19258681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
    Nosadini R; Tonolo G
    J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.
    Arnold SV; Bhatt DL; Barsness GW; Beatty AL; Deedwania PC; Inzucchi SE; Kosiborod M; Leiter LA; Lipska KJ; Newman JD; Welty FK;
    Circulation; 2020 May; 141(19):e779-e806. PubMed ID: 32279539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of coronary heart disease in type 2 diabetes.
    Mykkänen L
    Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of coronary artery disease in diabetic patients with lower limb critical ischaemia: assessment of operational risk, drug therapy and indications for interventions].
    Dedov II; Kalashnikov VIu; Terekhin SA; Melkozerov KV
    Angiol Sosud Khir; 2012; 18(1):9-19. PubMed ID: 22836323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy.
    Zellweger MJ; Maraun M; Osterhues HH; Keller U; Müller-Brand J; Jeger R; Pfister O; Burkard T; Eckstein F; von Felten S; Osswald S; Pfisterer M
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):1001-10. PubMed ID: 25240454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus.
    Wilson SH; Kennedy FP; Garratt KN
    Drugs Aging; 2001; 18(5):325-33. PubMed ID: 11392441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of hypertension in type 2 diabetes mellitus--2002 update].
    Teuscher AU; Diem P
    Ther Umsch; 2002 Aug; 59(8):422-8. PubMed ID: 12235735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.
    Norhammar A; Malmberg K; Diderholm E; Lagerqvist B; Lindahl B; Rydén L; Wallentin L
    J Am Coll Cardiol; 2004 Feb; 43(4):585-91. PubMed ID: 14975468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.